Home > Products > CD64 & GD2
> Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-Fv)
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-126)
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD64 antibody variable domain is fused to the C terminal of an IgG of anti-GD2 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-Fv) (BSGV-126). Click the button below to contact us or submit your feedback about this product.